Stockreport

Erasca Reports Fourth Quarter and Full Year 2024 Business Updates and Financial Results

Erasca, Inc.  (ERAS) 
PDF Potentially best-in-class RAS-targeting franchise advancing with both ERAS-0015 and ERAS-4001 expected to enter the clinic in 2025 Ongoing Phase 3 SEACRAFT-2 registrati [Read more]